4

Changes in Ownership

C4 Therapeutics, Inc. Filed 2020-10-06 Acc 0000899243-20-027696

Director acquired 152,446 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider	Date	Transaction	Shares	Price	Value	Owned after	D/I
Anderson Kenneth Carl Director	2020-10-06	Conversion	+18,040			80,376	D
Anderson Kenneth Carl Director	2020-10-06	Conversion	+18,040			45,038	I
Anderson Kenneth Carl Director	2020-10-06	Conversion	+41,244			63,543	I
Anderson Kenneth Carl Director	2020-10-06	Conversion	+41,244			63,543	I
Anderson Kenneth Carl Director	2020-10-06	Conversion	+16,939			16,939	I
Anderson Kenneth Carl Director	2020-10-06	Conversion	+16,939			16,939	I
Derivatives
Anderson Kenneth Carl Director	2020-10-06	Conversion · Series A Preferred Stock	−152,160			0	D
Anderson Kenneth Carl Director	2020-10-06	Conversion · Series A Preferred Stock	−152,160			0	I
Anderson Kenneth Carl Director	2020-10-06	Conversion · Series A Preferred Stock	−347,840			0	I
Anderson Kenneth Carl Director	2020-10-06	Conversion · Series A Preferred Stock	−347,840			0	I
Anderson Kenneth Carl Director	2020-10-06	Conversion · Series B Preferred Stock	−142,857			0	I
Anderson Kenneth Carl Director	2020-10-06	Conversion · Series B Preferred Stock	−142,857			0	I